Share

All Updates

June 29, 2022
New Jersey

Today, the New Jersey legislature passed the state’s operating budget. Included in that budget was an increase of $1.5 million in funding for the New Jersey Cancer Education and Early Detection (NJCEED) program for a total of $5 million.

June 24, 2022
National

As a nonprofit entity whose mission is improving the lives of people with cancer and their families, the American Cancer Society isn’t taking sides on the decision. However, the decision will impact cancer patients and their families and is likely to disproportionately effect communities of color.

June 24, 2022
Michigan

Michigan legislature passed a package of bills they say will help reduce Big Tobacco’s grip on Michigan, but these bills are a wolf in sheep’s clothing.

June 23, 2022

Today the U.S. Food and Drug Administration (FDA) announced it will issue marketing denial orders to all JUUL e-cigarette products.

June 23, 2022
California

The majority of Imperial residents know that secondhand smoke is harmful and support smoke-free policies that protect their families, friends and neighbors. A new billboard campaign aims to prompt city leaders into action with a strong message: Secondhand smoke doesn’t belong here.

June 23, 2022
National

The nation’s leading organizations from across the health care spectrum are calling on Congress to extend the expanded Affordable Care Act (ACA) health care premium tax credits.

June 23, 2022
National

The nation’s leading organizations from across the health care spectrum are calling on Congress to extend the expanded Affordable Care Act (ACA) health care premium tax credits.

June 22, 2022
North Carolina

RALEIGH, NC – June 22, 2022 – A new series of advertisements paid for by the American Cancer Society Cancer Action Network (ACS CAN) that launched last week will be paused following recent progress in the House to expand Medicaid. The below is a statement on behalf of ACS

June 21, 2022
California

The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.